Activation of Src kinases p53/56(lyn) and p59(hck) by p210(bcr/abl) in myeloid cells

Cancer Research

Volumn 56, Issue 15, 1996, Pages 3589-3596

  Danhauser Riedl, Susanne ^a   Warmuth, Markus ^a   Druker, Brian J ^b   Emmerich, Bertold ^a   Hallek, Michael ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; CHROMOSOME 9; CHROMOSOME TRANSLOCATION 22; CHRONIC MYELOID LEUKEMIA; ENZYME ACTIVATION; MOUSE; NONHUMAN; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL;

CYTOSOL; ENZYME ACTIVATION; FUSION PROTEINS, BCR-ABL; HUMANS; INTERLEUKIN-3; LEUKEMIA, MYELOID, CHRONIC; PHOSPHOPROTEINS; PHOSPHORYLATION; PRECIPITIN TESTS; SRC-FAMILY KINASES; TRANSFECTION; TUMOR CELLS, CULTURED; TYROSINE;

EID: 0029683347     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Groffen, J., Stephenson, J. R., Heisterkamp, N., de Klein, A., Bartram, C. R., and Grosveld, G. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22 Cell. 36: 93-99, 1984.
2. Ben, N. Y., Daley, G. Q., Mes, M. A. M., Witte, O. N., and Baltimore, D. The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene. Science (Washington DC), 233: 212-214, 1986.
3. Daley, G. Q., and Ben, N. Y. Implicating the bcr/abl gene in the pathogenesis of Philadelphia chromosome-positive human leukemia. Adv. Cancer Res., 57: 151-84, 1991.
4. Hallek, M., Danhauser-Riedl, S., Herbst, R., Warmuth, M., Winkler, A., Kolb, H-J., Druker, B., Emmerich, B., Griffin, J. D., and Ullrich, A. Interaction of the receptor tyrosine kinase p145c-kit with the p210bcr/abl kinase in myeloid cells. Br. J. Haematol., in press, 1996.
5. BCR/ABL. J. Biol. Chem., 270: 5039-5047, 1995.
6. Feller, S. M., Ren, R., Hanafusa, H., and Baltimore, D. SH2 and SH3 domains as molecular adhesives: the interactions of Crk and Abl Trends Biochem. Sci., 19: 453-458, 1994.
7. + leukemia. Blood, 84: 1731-1736, 1994.
8. Reuther, G. W., Fu, H., Cripe, L. D., Collier, R. J., and Pendergast, A. M. Association of the protein kinases c-Bcr and Bcr-Abl with proteins of the 14-3-3 family Science (Washington DC), 266: 129-133, 1994.
9. Tauchi, T., Boswell, H. S., Leibowitz, D., and Broxmeyer, H. E. Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to Ras-activation pathway. J. Exp. Med., 179: 167-175, 1994.
10. Pendergast, A. M., Quilliam, L. A., Cripe, L. D., Bassing, C. H., Dai, Z., Li, N., Batzer, A., Rabun, K. M., Der, C. J., Schlessinger, J., and Gishizky, M. L. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell, 75: 175-185, 1993.
11. Druker, B., Okuda, K., Matulonis, U., Salgia, R., Roberts, T., and Griffin, J. D. Tyrosine phosphorylation of rasGAP and associated proteins in chronic myelogenous leukemia cell lines. Blood, 79: 2215-2220, 1992.
12. bcr/abl J. Biol. Chem., 269: 5016-5021, 1994.
13. Matulonis, U., Salgia, R., Okuda, K., Druker, B., and Griffin, J. D. Interleukin-3 and p210 BCR/ABL activate both unique and overlapping pathways of signal transduction in a factor-dependent myeloid cell line. Exp. Hematol., 21: 1460-1466, 1993.
14. BCR/ABL and Ph+ ALL involve GTPase-activating protein, phospholipase C-γ1, and phosphatidylinositol 3′-kinase. Leukemia (Baltimore), 8: 115-120, 1994.
15. Torigoe, T., O'Connor, R., Fagard, R., Fischer, S., Santoli, D., and Reed, J. C. Regulation of SRC-family protein tyrosine kinases by interleukins, IL-2, and IL-3. Leukemia (Baltimore), 6: 345-375, 1992.
16. Torigoe, T., O'Connor, R., Santoli, D., and Reed, J. C. Interleukin-3 regulates the activity of the LYN protein-tyrosine kinase in myeloid-committed leukemic cell lines. Blood, 80: 617-624, 1992.
17. Ernst, M., Gearing, D. P., and Dunn, A. R. Functional and biochemical association of Hck with the LIF/IL-6 receptor signal transducing subunit gp130 in embryonic stem cells. EMBO J., 13: 1574-1584, 1994.
18. Corey, S., Eguinoa, A., Puyana-Theall, K., Bolen, J. B., Cantley, L., Mollinedo, F., Jackson, T. R., Hawkins, P. T., and Stephens, L. R. Granulocyte macrophage-colony stimulating factor stimulates both association and activation of phosphoinositide 3OH-kinase and src-related tyrosine kinase(s) in human myeloid derived cells. EMBO J., 12: 2681-2690, 1993.
19. Laneuville, P., and Sullivan, A. K. Clonal succession and deletion of bcr/abl sequences in chronic myelogenous leukemia with recurrent lymphoid blast crisis. Leukemia (Baltimore), 5: 752-756, 1991.
20. Hallek, M., Druker, B., Lepisto, E. M., Wood, K. M., Ernst, T. J., and Griffin, J. D. Granulocyte-macrophage colony-stimulating factor and Steel factor induce phosphorylation of both unique and overlapping signal transduction intermediates in a human factor dependent hematopoietic cell line. J. Cell. Physiol., 153: 176-186, 1992.
21. Daley, G. Q., Van Etten, R. A., and Baltimore, D. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science (Washington DC), 247: 824-830, 1990.
22. Pleiman, C. M., Clark, M. A., Gauen, L. K. T., Winitz, S., Coggeshall, K. M., Johnson, G. L., Shaw, A. S., and Cambier, J. C. Mapping of the sites of Src family of protein tyrosine kinases p55blk, p59fyn, p561yn which interact with the effector molecules phospholipase C-γ2, microtubule-associated protein kinase, GTPase-activating protein, and phosphatidylinositol 3-kinase. Mol. Cell. Biol., 13: 5877-5887, 1993.
23. Schlessinger, J. How receptor tyrosine kinases activate ras. Trends Biochem. Sci., 18: 273-275, 1993.
24. ras. Trends Biochem Sci., 18: 250-254, 1993.
25. Hallek, M. Tyrosine kinases and phosphatases in hematopoietic growth factor signaling In: Herrmann, F., and Mertelsmann, R. (eds.), Advances in Hematopoietic Growth Factors pp. 19-48. New York: Marcel Dekker, 1994.
26. Brott, B. K., Decker, S., Shafer, J., Gibbs, J. B., and Jove, R. GTPase-activating protein interactions with the viral and cellular Src kinases. Proc. Natl. Acad. Sci. USA, 88: 755-759, 1991.
27. Seidel-Duncan, C., Meyer, B. E., Thomas, S. M., and Brugge, J. S. Effects of SH2 and SH3 deletion mutants on the functional activities of wild-type and transforming variants of c-Src. Mol. Cell. Biol., 12: 1835-1845, 1992.
28. Koch, C. A., Moran, M. F., Anderson, D., Liu, X., Mbamalu, G., and Pawson, T. Multiple SH2-mediated interactions in v-src-transformed cells. Mol. Cell. Biol., 12: 1366-1374, 1992.
29. Briggs, S. D., Bryant, S. S., Jove, R., Sanderson, D., and Smithgall, T. E. The ras GTPase-activating protein (GAP) is an SH3 domain-binding protein and substrate for the Src-related tyrosine kinase, Hck. J. Biol. Chem., 270: 14718-14724, 1995.
30. McGlade, J., Cheng, A., Pelicci, G., Pelicci, P. G., and Pawson, T. Shc proteins are phosphorylated and regulated by the v-Src and v-Fps protein-tyrosine kinases. Proc. Natl. Acad. Sci. USA, 89: 8869-8873, 1992.
31. Maa, M-C., Leu, T-H., McCarley, D. J., Schatzman, R. C., and Parsons, S. J. Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers. Proc. Natl. Acad. Sci. USA, 92: 6981-6985, 1995.
32. Goga, A., McLaughlin, J., Afar, D. E., Saffran, D. C., and Witte, O. N. Alternative signals to RAS for hematopoietic transformation by the BCR/ABL oncogene. Cell, 82: 981-988, 1995.
33. Cortez, D., Kadlec, L., and Pendergast, A. M. Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis. Mol. Cell. Biol., 15: 5531-5541, 1995.
34. Maru, Y., Peters, K. L., Afar, D. E. H., Shibuya, M., Witte, O. N., and Smithgall, T. E. Tyrosine phosphorylation of BCR by FPS/FES protein-tyrosine kinases induces association of BCR with GRB-2/SOS. Mol. Cell. Biol., 15: 835-842, 1995.
35. Varmus, H. E., and Lowell, C. A. Cancer genes and hematopoiesis. Blood, 83: 5-9, 1994.
36. Abraham, K. M., Levin, S. D., Marth, J. D., Forbush, K. A., and Perlmutter, R. M. Delayed thymocyte development induced by augmented expression of p561ck. J. Exp. Med., 173: 1421-1432, 1991.